BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 24636754)

  • 21. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
    Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
    Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pheochromocytoma and paraganglioma].
    Gimenez-Roqueplo AP
    Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
    Pacak K; Eisenhofer G; Ahlman H; Bornstein SR; Gimenez-Roqueplo AP; Grossman AB; Kimura N; Mannelli M; McNicol AM; Tischler AS;
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):92-102. PubMed ID: 17237836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
    Fishbein L; Del Rivero J; Else T; Howe JR; Asa SL; Cohen DL; Dahia PLM; Fraker DL; Goodman KA; Hope TA; Kunz PL; Perez K; Perrier ND; Pryma DA; Ryder M; Sasson AR; Soulen MC; Jimenez C
    Pancreas; 2021 Apr; 50(4):469-493. PubMed ID: 33939658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative genetic diagnostics and imaging for pediatric pheochromocytoma and paraganglioma].
    Dralle H
    Chirurg; 2019 Mar; 90(Suppl 2):107. PubMed ID: 30758582
    [No Abstract]   [Full Text] [Related]  

  • 27. Personalized Management of Pheochromocytoma and Paraganglioma.
    Nölting S; Bechmann N; Taieb D; Beuschlein F; Fassnacht M; Kroiss M; Eisenhofer G; Grossman A; Pacak K
    Endocr Rev; 2022 Mar; 43(2):199-239. PubMed ID: 34147030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of pheochromocytoma and paraganglioma: new developments.
    Pigny P; Cardot-Bauters C
    Ann Endocrinol (Paris); 2010 Mar; 71(2):76-82. PubMed ID: 20031114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing patients with hereditary paraganglial tumours.
    Erlic Z; Neumann HP
    Lancet Oncol; 2009 Aug; 10(8):741. PubMed ID: 19647193
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
    Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
    Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pheochromocytoma and paraganglioma in children and adolescents.
    Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
    Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene targeting through o-methylated catecholamine metabolite patterns.
    Shine B
    Clin Chem; 2011 Mar; 57(3):361-2. PubMed ID: 21245368
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent advances in adrenal diseases].
    Gruber M; Eisenhofer G; Fassnacht M; Bornstein SR
    Dtsch Med Wochenschr; 2011 Oct; 136(40):1998-2001. PubMed ID: 21960326
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pheochromocytoma and paraganglioma in childhood: a report of 2 cases report].
    Mosquera Gorostidi A; Justo Ranera A; Zakirian Denis SE; González Temprano N; Sagaseta de Ilúrdoz Uranga M; Molina Garicano J
    An Pediatr (Barc); 2015 Jan; 82(1):e175-80. PubMed ID: 25082130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    Lenders JWM; Kerstens MN; Amar L; Prejbisz A; Robledo M; Taieb D; Pacak K; Crona J; Zelinka T; Mannelli M; Deutschbein T; Timmers HJLM; Castinetti F; Dralle H; Widimský J; Gimenez-Roqueplo AP; Eisenhofer G
    J Hypertens; 2020 Aug; 38(8):1443-1456. PubMed ID: 32412940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.